Virtua Clinical Trials

IRB-2021-02

The Effectiveness of a Structured Smoking Cessation Program versus Unassisted Smoking Cessation Methods in Cancer Patients Managed in a Community Health System.

Patients are asked to participate in this research study because they have been diagnosed with cancer and are actively smoking.

Previous studies have found that patients who smoke after a cancer diagnosis and are treated with chemotherapy often have more side effects such as infection, fatigue, heart and lung problems and weight loss. Those patients who receive radiation also suffer more side effects such as dry mouth, mouth sores and loss of taste. Even early stage cancer patients who only require surgery also have increased side effects. Their wounds take a longer amount of time to heal and once they heal they are likely to have more scars.

The purpose of the study is to determine the effectiveness of an intensive structured smoking cessation program versus unassisted smoking cessation quitting methods in cancer patients seen in a community health care system.

Click Here for more information

Principle Investigator: Theresa M. Carducci, MSN, RN, BA, CCRP

Clinical Trials for All Sites